

Für Resident- und Mitgliedsteams
CLIC fördert eine lebendige Gemeinschaft von Gründer:innen, in der Start-ups von einem Netzwerk aus Mentori:nnen profitieren, inklusive von Führungskräften aus der Industrie, Wissenschaftler:innen r sowie erfahrene Unternehmer:innen.
Durch CEO-/CSO-Roundtables, Workshops und Peer-Learning-Sessions erhalten Gründer:innen das notwendige Wissen und wertvolle Einblicke, um Herausforderungen zu bewältigen und ihre Innovationen weiterzuentwickeln.
Regelmäßige Community-Building-Veranstaltungen bieten zusätzliche Möglichkeiten, Kontakte zu potenziellen Partnern, Investor:innen sowie Kooperationspartnern aufzubauen.
Vergangene Veranstaltungen
-
08.07.2026 | Finance Fundamentals for APT Founders

CLIC Workshop Series 2026 #4
Topic on Regulatory Affairs and Business Development
Trainer: Tobias Jäger
A one-day finance workshop designed for scientist- and clinician-founders in CLIC's portfolio. The curriculum assumes no prior business background and uses APT-specific examples — long development timelines, milestone-driven valuation, and capital intensity. Each module pairs concepts with a hands-on exercise, and the afternoon includes an investor panel built around questions submitted by participants in advance.
Content:
- The biotech financing landscape
- Non-dilutive funding strategy
- Cap tables, dilution & valuation
- Term sheets demystified
- Financial modeling & runway
- The investor conversation
-
24.06.2026 | Cell Health Assays - Lunch & Learn
Technology Driven Workshop
Lunch & Learn Workshop Promega
Cell health assays provide critical insights into the vitality and condition of your cells. They are used in a wide range of applications—such as assessing the toxicity of potential drug candidates, analyzing cellular changes in cancer research, or conducting fundamental cell biology studies. This seminar provides an overview of modern, highly sensitive assays for the precise and reliable determination of cell viability, cytotoxicity, apoptosis, and oxidative stress.
Content:
- Overview of the various assay formats
- What are the advantages and limitations of assay selection?
- Kinetic assays for real-time measurements
- Assays optimized for 3D cell cultures
- How to generate more data from a single sample
-
12.05.2026 | CMC in ATMPs -Let’s talk ATMP

CLIC Workshop Series 2026 #3
Topic on Regulatory Affairs and Business Development
Valicare
A workshop on GMP for ATMP and their regulatory requirements
Content:
- Individualized Therapies - Current regulatory perspective; 20 min Presentation & 10 min QA
- GMP regulatory framework with current news and outlook; 20 min Presentation & 10 min QA
- Impuls lecture on requirements to starting and ancillary materials for ATMPs (10min) followed by a hands-on session: QTTP to Specification of a starting material
- Supplier qualification management and supplier qualification audit in GMP; 20 min Presentation & 10 min QA
- Open format exchange on: Selecting, qualifying and handling a contract manufacturing organization 45 min
With Speaker and Moderators:
Dr. Robert Zoubek, Granzer Regulatory Consulting & Services GmbH
Dr. Hans-Georg Eckert, Valicare GmbH
Dr. Stefan Löffler, Valicare GmbH -
06.05.2026 | Cell and Gene Therapy Solutions - Lunch & Learn

Technology Driven Workshop
Lunch & Learn Workshop Bio-Techne
Cell and Gene Therapy Solutions combined with an introduction to the ELLA and LUMINEX platforms
Content:
- Open Remarks and Bio-Techne Introduction
- Enabling Journey from Research to Translational with Right Quality Reagents
- Immunoassay Solutions for QC in Clinical Applications
- CheckImmune GmbH - Validation and real life observations of cytokine quantification assays used in clinical studies
- Lunch & Networking
-
21.04.2026 | Strategy Sprints for Early-Stage Drug & Platform Development

CLIC Workshop Series 2026 # 2
Topic on Regulatory Affairs and Business Development
Trainer: Dr. Marisela Rodriguez
Early-stage drug and platform innovators often have a clear vision yet struggle to transform their ideas into cohesive development roadmaps. We offer short, facilitated sprints that help teams build their strategy and Target Product Profile (TPP) / Platform Target Profile (PTP), resolving two key bottlenecks that stall early-stage programs: unclear choices and product characteristics. Teams leave empowered to move past early friction points and execute without added complexity.
-
24.03.2026 | From Concept to Submission: Understanding CTA & IMPD Fundamentals, going into Clinical Trial

CLIC Workshop Series 2026 # 1
Topic on Regulatory Affairs and Business Development
Trainer: Maja Pizevska
This first CLIC workshop will focus on the core components and structure of a Clinical Trial Application (CTA), with particular emphasis on the Investigational Medicinal Product Dossier (IMPD). The workshop is designed to provide a clear and practical overview of what a CTA entails and how the IMPD fits within the overall submission package.
The session serves as a preparatory step for more in-depth workshops on CMC, potency assays, and regulatory considerations, which will follow in May.
-
27.10.2025 | Sharpen Your Science Storytelling & Investor Pitch
CLIC Workshop 2025
Topic on Regulatory Affairs and Business Development
Trainer: Mansa Schroff
Session A – Marketing & Communications for Science Entrepreneurs
Learn to tailor your messaging for investors, clinicians, patients, and corporate partners using the COMPASS Message Box method. Through interactive exercises and micro-coaching, you will leave with repeatable tools and templates for effective outreach.Session B – Pitching Practice: From Science to a 3-Slide Investor Story
Distill your complex science into a crisp, investor-ready narrative. Working in small groups, you will build concise pitches, practice delivery, and receive live feedback. You will also take home templates, an elevator pitch framework, and an investor Q&A checklist. -
15.07.2025 | Opening of the BIH Clinical Incubator

The BIH Clinical Incubator (CLIC) officially opened its doors on July 15, 2025, at the Rahel Hirsch Center.
The CLIC team invited representatives from research, industry and the non-profit sector to the reception. In his opening speech, Prof. Dr. Christopher Baum, Chair of the BIH Board of Directors and Chief Translational Research Officer of Charité – Universitätsmedizin Berlin, emphasised the importance of CLIC for implementation of the BIH strategy and specifically for the future of ATMPs. Together with the Berlin Center for Gene and Cell Therapies (BC-GCT) which is planned to open in 2028, CLIC will promote advanced therapeutic research and connect the BIH, Charité - Universitätsmedizin Berlin and the other Advance and Personalized Therapy (APT) communities across Europe.





